Institutional Biosafety Committee
The Institutional Biosafety Committee (IBC) is responsible for reviewing all research that involves the use of recombinant DNA in accord with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules and ensuring that the proposed activities comply with the federal regulations governing them.
-
NIH Research Category Assistant
NIH Research Category Agent is a guidance tool designed to help researchers identify which section of the NIH Guidelines best aligns with their work involving recombinant or synthetic nucleic acid molecules. An analysis of a brief description of a research project provides a recommended category along with a concise explanation of why it is the best fit.
-
What research does the CU IBC review and approve?
- Use of recombinant DNA or synthetic nucleic acid molecules
- Use of hazardous biological agents (BSL-2 and above)
- Use of select agents or toxins
- Use of nanomaterials with any of the above categories
See the IBC Resources Page for additional information.
-
How do I get started?
Access the General IBC FAQ for common questions.
-
How do I obtain approval to do my research?
All research requests and modifications are submitted using the InfoEd electronic submission system. Access InfoEd by clicking here or use the menu above or the buttons below.
- How are IBC protocols reviewed?
